Skip to main content
Signal8

Stemtech Corp (STEK)

Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.

Sector: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Industry: Drug Manufacturers - Specialty & Generic

Stemtech Corporation logo

Stemtech Corporation

OTC:STEKHealthcare
$0.0001
Mkt Cap$300K
EV-
Float2.7B
O/S3B
VOL1.5M sh
$ Vol$150
RVOL0.13×
Inst Own-
Net Cash/Sh-
Dilution
FormDescription
10-Q
10-Q
10-Q
10-K
NT 10-Q/A
AMENDMENT NO 1
NT 10-Q
NOTICE OF LATE FILING
NT 10-K
EXTENSION FOR DECEMBER 2025 10-K
10-Q
FORM 10-Q FOR SEP 2025
NT 10-Q
09-30-25 10-Q EXTENSION
10-Q
FORM 10-Q FOR JUN 2025
NT 10-Q
EXTENSION
10-Q
FORM 10-Q FOR MAR 2025
10-K
FORM 10-K FOR DEC 2024
4
PRIMARY DOCUMENT
NT 10-Q/A
AMENDED EXTENSION REQUEST
NT 10-Q
10-Q EXTENSION
8-K
STEMTECH
NT 10-K
EXTENSION
8-K
CURRENT REPORT
8-K
CURRENT REPORT
8-K
CURRENT REPORT
10-Q
FORM 10-Q FOR SEPTEMBER 30, 2024
NT 10-Q
EXTENSION
RW
REGISTRATION WITHDRAWL
10-Q
FORM 10-Q FOR JUNE 2024

1-25 of 160

…

Recent SEC filings with analysis

    Stemtech Corp (STEK) SEC Filings: 10-K, 10-Q, 8-K, Form 4 | Signal8